News from the South African Tuberculosis Vaccine Initiative.

Latest Research: Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial
Associate Professor Michele Tameris has co-authored a paper titled: Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E in people living with HIV in South Africa, appearing in the Lancet HIV journal.
Read more

UPCOMING Seminar: 23 July 2025 Beyond the Cough: Non-Sputum Strategies for TB Diagnosis
On Wednesday 23 July 2025, Dr Simon Mendelsohn will present a paper titled: "Beyond the Cough: Non-Sputum Strategies for TB Diagnosis" at a IDM seminar.
Read more

Latest Research: Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C
Professor Tom Scriba has co-authored a paper titled: "Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C" in Vaccine journal
Read more

Latest Research: The participation of people deprived of liberty in tuberculosis vaccine trials
SATVI Director, Professor Mark Hatherill has co-authored an article in which the authors argue that people in prison have the right to participate in biomedical research, as long as their autonomy and rights are fully respected.
Read more
Vacancies
No vacancies found
Upcoming Events
IDM CPD-ACCREDITED SEMINAR: Beyond the Cough: Non-Sputum Strategies for TB Diagnosis
(Ends 23 July 2025)
More infoDr Simon Mendelsohn will present a seminar titled: "Beyond the Cough: Non-Sputum Strategies for TB Diagnosis"
2025 Union Conference on Lung Health, 18-22 November 2025
(Ends 22 November 2025)
More infoThe world's largest lung health conference, the World Conference on Lung Health, will take place at the Bella Center in Copenhagen, Denmark from 18-22 November 2025.